Oncolytic herpes simplex virus boosts antitumor immunity by forming tertiary lymphoid structures
Author Information
Author(s): Zhang Meng‐Jie, Lin Wen‐Ping, Wang Qing, Wang Shuo, Song An, Wang Yuan‐Yuan, Li Hao, Sun Zhi‐Jun
Primary Institution: Wuhan University
Hypothesis
The study investigates the role of oncolytic herpes simplex virus (oHSV) in inducing tertiary lymphoid structure (TLS) formation to enhance antitumor immunity.
Conclusion
The findings indicate that oHSV promotes TLS formation and enhances the immune response, improving cancer treatment outcomes.
Supporting Evidence
- oHSV therapy significantly suppressed tumor growth in both tumor models.
- TLS formation was observed in 5 out of 16 tumors in the HNSCC model.
- CXCL10 and CXCR3 were identified as favorable prognostic factors for cancer patients.
Takeaway
This study shows that a special virus can help the body fight cancer better by making new structures that help immune cells work together.
Methodology
The study used mouse models of cancer to assess the effects of oHSV on TLS formation and immune cell infiltration.
Participant Demographics
C57BL/6 female mice, aged 6–8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website